276 related articles for article (PubMed ID: 6241847)
41. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
42. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Shah PM; Ottnad-Walz M; Stille W
Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
[TBL] [Abstract][Full Text] [Related]
43. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL
J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021
[TBL] [Abstract][Full Text] [Related]
44. In vitro susceptibility of new generation of antibacterial antibiotics against pathogenic bacteria.
Singh V; Jain SK
Hindustan Antibiot Bull; 1999; 41(1-4):41-4. PubMed ID: 12024980
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
Baltch AL; Sutphen NT; Smith RP; Conley PE
Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
[TBL] [Abstract][Full Text] [Related]
46. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
Xicota MA; Coll R; Esteve M; Moros M; Parés J
Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.
Zampini IC; Cuello S; Alberto MR; Ordoñez RM; D' Almeida R; Solorzano E; Isla MI
J Ethnopharmacol; 2009 Jul; 124(3):499-505. PubMed ID: 19467313
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of in vitro activity of ciprofloxacin and pefloxacin against strains isolated from clinical material].
Kumelj M; Rus A; Music E
Plucne Bolesti; 1989; 41(3-4):193-5. PubMed ID: 2636406
[TBL] [Abstract][Full Text] [Related]
49. Resistance to quinolones in pathogens causing urinary tract infections.
Kapoor H; Aggarwal P
J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
[TBL] [Abstract][Full Text] [Related]
50. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P
Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711
[TBL] [Abstract][Full Text] [Related]
51. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
[TBL] [Abstract][Full Text] [Related]
52. Antibacterial activity of norfloxacin.
Norrby SR; Jonsson M
Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
[TBL] [Abstract][Full Text] [Related]
53. In vitro activity of the new 4-quinolone compound Ro 23-6240.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
[TBL] [Abstract][Full Text] [Related]
54. Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.
Jones BM; Geary I; Lee ME; Duerden BI
J Antimicrob Chemother; 1986 Jun; 17(6):739-46. PubMed ID: 3460983
[TBL] [Abstract][Full Text] [Related]
55. In vitro activity of MC-352, a new 16-membered macrolide.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
[TBL] [Abstract][Full Text] [Related]
56. In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents.
Mandell W; Neu HC
Antimicrob Agents Chemother; 1986 May; 29(5):852-7. PubMed ID: 3729343
[TBL] [Abstract][Full Text] [Related]
57. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Forsgren A
Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
[TBL] [Abstract][Full Text] [Related]
58. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Hoogkamp-Korstanje JA
Eur J Clin Microbiol; 1984 Aug; 3(4):333-8. PubMed ID: 6237901
[TBL] [Abstract][Full Text] [Related]
59. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
60. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
Esposito S; Galante D; Pennucci C; Barba D
Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
